Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC).

Jeffrey Graham,Connor Wells,Shaan Dudani,Chun Loo Gan,Frede Donskov,Jae-Lyun Lee,Christian K. Kollmannsberger,Sumanta K. Pal,Benoit Beuselinck,Aaron R. Hansen,Scott North,Georg A. Bjarnason,Neeraj Agarwal,Ravindran Kanesvaran,Lori Wood,Sebastien J. Hotte,Rana R. McKay,Toni K. Choueiri,Daniel Yick Chin Heng

Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC).

2021

Jeffrey Graham
Connor Wells
Shaan Dudani
Chun Loo Gan
Frede Donskov
Jae-Lyun Lee
Christian K. Kollmannsberger
Sumanta K. Pal
Benoit Beuselinck
Aaron R. Hansen
Scott North
Georg A. Bjarnason
Neeraj Agarwal
Ravindran Kanesvaran
Lori Wood
Sebastien J. Hotte
Rana R. McKay
Toni K. Choueiri
Daniel Yick Chin Heng

316Background: Immune checkpoint inhibitors (ICI) have demonstrated impressive activity in metastatic clear-cell renal cell carcinoma (ccRCC) and have become standard treatment options in this sett...

Keywords:

Cancer research
Clear cell renal cell carcinoma
immune checkpoint inhibitors
Medicine
first line

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations